Holen Sie sich die Stockscreener-App
291.76
0.39%
-1.13
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$292.89
Offen:
$292.89
24-Stunden-Volumen:
1.38M
Relative Volume:
0.62
Marktkapitalisierung:
$157.07B
Einnahmen:
$34.76B
Nettoeinkommen (Verlust:
$6.62B
KGV:
23.87
EPS:
12.223
Netto-Cashflow:
$10.61B
1W Leistung:
-2.36%
1M Leistung:
+4.49%
6M Leistung:
+4.26%
1J Leistung:
-7.58%
1-Tages-Spanne:
$290.66
$293.94
1-Wochen-Bereich:
$290.66
$303.85
52-Wochen-Spanne:
$253.30
$335.88
Amgen Inc Stock (AMGN) Company Profile
Firmenname
Amgen Inc
Sektor
Telefon
(805)447-1000
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Vergleichen Sie AMGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
291.76 | 157.68B | 34.76B | 6.62B | 10.61B | 12.22 |
|
LLY
Lilly Eli Co
|
825.45 | 736.03B | 53.26B | 13.80B | -50.20M | 15.08 |
|
JNJ
Johnson Johnson
|
190.40 | 463.72B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
227.99 | 403.22B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
NVS
Novartis Ag Adr
|
130.36 | 254.84B | 53.40B | 13.68B | 16.89B | 6.8864 |
|
MRK
Merck Co Inc
|
87.49 | 217.76B | 63.43B | 16.42B | 14.72B | 6.4861 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Fortgesetzt | Raymond James | Mkt Perform |
| 2025-05-20 | Fortgesetzt | Guggenheim | Neutral |
| 2025-04-22 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-14 | Eingeleitet | Citigroup | Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Outperform |
| 2024-10-14 | Herabstufung | Truist | Buy → Hold |
| 2024-09-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-02-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-11-02 | Hochstufung | Truist | Hold → Buy |
| 2023-10-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-17 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Fortgesetzt | BofA Securities | Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-24 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Bestätigt | Truist | Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-31 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-02-09 | Bestätigt | Barclays | Equal Weight |
| 2022-02-09 | Bestätigt | Jefferies | Buy |
| 2022-02-09 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-09 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2021-12-06 | Eingeleitet | Goldman | Buy |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-09-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Eingeleitet | Daiwa Securities | Buy |
| 2020-10-28 | Eingeleitet | UBS | Neutral |
| 2020-10-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Hochstufung | Truist | Hold → Buy |
| 2020-10-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Herabstufung | Truist | Buy → Hold |
| 2020-10-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Fortgesetzt | Guggenheim | Neutral |
| 2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-03-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-01-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-17 | Fortgesetzt | Morgan Stanley | Overweight |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-11-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-19 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-05-23 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Amgen Inc Aktie (AMGN) Neueste Nachrichten
What dividend safety score for Amgen Inc. stockMarket Volume Report & Weekly Chart Analysis and Trade Guides - newser.com
Why global investors buy Amgen Inc. (AMG0) stockEntry Point & Expert Curated Trade Setup Alerts - newser.com
What is the fair value estimate for Amgen Inc. (AMG) stock in 2025July 2025 Market Mood & Real-Time Chart Pattern Alerts - newser.com
Amgen's (AMGN) "Buy (B-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Will Amgen Inc. (AMG0) stock extend growth storyGap Up & Breakout Confirmation Trade Signals - newser.com
Will Amgen Inc. (AMG0) stock recover faster than industry2025 Momentum Check & Fast Moving Stock Watchlists - newser.com
Amgen, Inc. Experiences Revision in Its Stock Evaluation Amid Market Dynamics - Markets Mojo
Will Amgen Inc. (AMG0) stock profit from AI boomQuarterly Profit Report & Free Technical Confirmation Trade Alerts - newser.com
Why global investors buy Amgen Inc. (AMG) stock2025 Technical Patterns & Stepwise Entry/Exit Trade Alerts - newser.com
UBS Raises PT on Amgen Inc. (AMGN) to $326 From $315, Keeps a Neutral Rating - MSN
Amgen Inc. stock daily chart insightsMarket Activity Report & Risk Controlled Daily Trade Plans - newser.com
Will Amgen Inc. (AMG0) stock outperform energy sector in 2025Trade Risk Summary & Technical Buy Zone Confirmations - newser.com
Should I buy Amgen Inc. (AMG0) stock before earnings seasonTreasury Yields & AI Enhanced Market Trend Forecasts - newser.com
Biogen Takes Aim At Amgen’s Tavneos With Vanqua Licensing Pact - Citeline News & Insights
The Zacks Analyst Blog Highlights Amazon.com, Wells Fargo, Amgen, IDT and Village Super Market - Zacks Investment Research
Sumitomo Mitsui Trust Group Inc. Has $475.22 Million Holdings in Amgen Inc. $AMGN - MarketBeat
ESMO 25: What Was Behind Bemarituzumab’s Waning Efficacy In FORTITUDE-101? - Citeline News & Insights
Moloney Securities Asset Management LLC Sells 2,270 Shares of Amgen Inc. $AMGN - MarketBeat
Sector Gamma AS Reduces Stock Position in Amgen Inc. $AMGN - MarketBeat
Asset Management One Co. Ltd. Boosts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
FSM Wealth Advisors LLC Invests $440,000 in Amgen Inc. $AMGN - MarketBeat
First Citizens Bank & Trust Co. Raises Stake in Amgen Inc. $AMGN - MarketBeat
Strategic Blueprint LLC Raises Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Rep. Lisa C. McClain Sells Off Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know - sharewise.com
Top Research Reports for Amazon.com, Wells Fargo & Amgen - Yahoo Finance
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Has $16.73 Million Stake in Amgen Inc. $AMGN - MarketBeat
Paralel Advisors LLC Purchases New Shares in Amgen Inc. $AMGN - MarketBeat
Bleakley Financial Group LLC Increases Stock Position in Amgen Inc. $AMGN - MarketBeat
Principle Wealth Partners LLC Lowers Stock Position in Amgen Inc. $AMGN - MarketBeat
Exencial Wealth Advisors LLC Decreases Position in Amgen Inc. $AMGN - MarketBeat
Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices - The New York Times
Halper Sadeh LLC Encourages Amgen Inc. Shareholders to Contact the Firm to Discuss Their Rights - The AI Journal
Amgen Inc. $AMGN Shares Purchased by Greatmark Investment Partners Inc. - MarketBeat
Ethic Inc. Boosts Position in Amgen Inc. $AMGN - MarketBeat
Amgen Abandons Patent For Way Of Boosting Drug Potency - Law360
Amgen Inc. $AMGN Shares Sold by ARK Investment Management LLC - MarketBeat
Amgen Inc. $AMGN Shares Bought by Parcion Private Wealth LLC - MarketBeat
AstraZeneca and Amgen’s Tezspire approved in EU for nasal polyps - Investing.com
Brookstone Capital Management Increases Stock Position in Amgen Inc. $AMGN - MarketBeat
Pacific Heights Asset Management LLC Boosts Holdings in Amgen Inc. $AMGN - MarketBeat
OMC Financial Services LTD Boosts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by D.A. Davidson & CO. - MarketBeat
Avidian Wealth Enterprises LLC Increases Stake in Amgen Inc. $AMGN - MarketBeat
AstraZeneca, Amgen's Severe Chronic Rhinosinusitis Drug Secures EU Approval - MarketScreener
Using flow based indicators on Amgen Inc.Rate Cut & Low Drawdown Momentum Trade Ideas - newser.com
Will Amgen Inc. (AMG0) stock benefit from mergersPortfolio Update Report & Growth Oriented Trading Recommendations - newser.com
Finanzdaten der Amgen Inc-Aktie (AMGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.17%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):